LOS ANGELES--(BUSINESS WIRE)--Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, will announce consolidated financial results for the twelve months ended December 31, 2008 and the fourth quarter of 2008 on Thursday, March 26 after close of market.
